Propellon Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Propellon General Information

Description

Developer of cancer therapies intended to target WDR5 protein. The company is working on WDR5 protein which is essential for assembly of methyltransferase complexes and proper histone modification, helping medical practitioners in the treatment of cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Ontario
  • Canada
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Ontario
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Propellon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition Completed Startup
1. Seed Round 22-Mar-2017 Completed Startup
To view Propellon’s complete valuation and funding history, request access »

Propellon Patents

Propellon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018328768-A1 Inhibitors of wdr5 protein-protein binding Inactive 06-Sep-2017
EP-3679031-A1 Inhibitors of wdr5 protein-protein binding Inactive 06-Sep-2017
EP-3679031-A4 Inhibitors of wdr5 protein-protein binding Inactive 06-Sep-2017
US-20200385371-A1 Inhibitors of wdr5 protein-protein binding Inactive 06-Sep-2017
WO-2019046944-A1 Inhibitors of wdr5 protein-protein binding Inactive 06-Sep-2017 C07D401/14
To view Propellon’s complete patent history, request access »

Propellon Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
FACIT Venture Capital Minority
To view Propellon’s complete investors history, request access »

Propellon FAQs

  • Where is Propellon headquartered?

    Propellon is headquartered in Canada.

  • What industry is Propellon in?

    Propellon’s primary industry is Drug Delivery.

  • Is Propellon a private or public company?

    Propellon is a Private company.

  • What is Propellon’s current revenue?

    The current revenue for Propellon is .

  • How much funding has Propellon raised over time?

    Propellon has raised $3M.

  • Who are Propellon’s investors?

    FACIT has invested in Propellon.

  • Who acquired Propellon?

    Propellon was acquired by Triphase Accelerator.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process